neuroAD is a novel, non-invasive medical device which has helped many Alzheimer’s Disease patients achieve sustained cognitive improvement. This treatment is typically combined with Alzheimer’s Disease medication, and offers new hope for patients to enjoy better quality of life.
neuroAD is an investigational device currently not commercially available in the United States.
neuroAD is CE-cleared and commercially available for the treatment of mild to moderate Alzheimer’s Disease in Europe.